BMEA
Biomea Fusion Inc
NASDAQ: BMEA · HEALTHCARE · BIOTECHNOLOGY
$1.74
+2.35% today
Updated 2026-09-11
Market cap
$126.12M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.18
Dividend yield
—
52W range
$1 – $3
Volume
1.3M
WallStSmart proprietary scores
19
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.5
Quality
B3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-12.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →251 stocks currently score above 75
Price targets
Analyst target
$6.50
+273.56%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy4 Buy0 Hold0 Sell1 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.07x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -12.64 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-10.03M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-80.02M | $-117.25M | $-138.43M | $-61.80M | $-8.33M |
| EPS | — | — | — | — | $-0.18 |
| Free cash flow | $-63.45M | $-99.96M | $-120.26M | $-70.37M | $-10.03M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Biomea Fusion Inc trades at $1.74. Our Smart Value Score of 19/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -12.64, it sits in the distress.
Frequently asked questions
What is Biomea Fusion Inc's stock price?
Biomea Fusion Inc (BMEA) trades at $1.74.
Is Biomea Fusion Inc overvalued?
Biomea Fusion Inc carries a Smart Value Score of 19/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Biomea Fusion Inc (BMEA)?
The 12-month analyst consensus target is $6.50, about 273.6% above the current $1.74. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Biomea Fusion Inc's Altman Z-Score is -12.64, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-189.40%
Beta-0.24
50D MA$1.42
200D MA$1.39
Shares out0.07B
Float0.07B
Short ratio—
Avg volume1.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—